Fadda Paola, Bedogni Francesco, Fresu Alessandra, Collu Maria, Racagni Giorgio, Riva Marco A
Department of Neuroscience B.B. Brodie, Center for Excellence in Neurobiology of Dependence, University of Cagliari, Cittadella Universitaria, Monserrato, Italy.
Biol Psychiatry. 2007 Aug 1;62(3):235-42. doi: 10.1016/j.biopsych.2006.08.003. Epub 2006 Dec 8.
Basic fibroblast growth factor (FGF2) plays a crucial role during the development of the cerebral cortex. Mice with a knockout of the FGF2 gene have a reduced number of glutamatergic neurons within the deep layers of the cerebral cortex.
We used molecular and behavioral analyses to investigate possible alterations in corticostriatal function in FGF2 -/- mice.
We found that FGF2 deficiency leads to decreased expression of presynaptic markers of integrity for glutamatergic fibers in the striatum, namely the membrane excitatory amino acid transporter 3 (EAAT3) and the vesicular glutamate transporter 1 (VGLUT1). The reduction of corticostriatal glutamatergic function in FGF2 -/- mice is associated with enhanced locomotor activity in a novel environment and increased responsiveness to dopaminergic drugs, such as cocaine or amphetamine. The behavioral alterations of FGF2 -/- can be normalized by injection of a low dose of the dopaminergic agonist apomorphine (.1 mg/kg) that reduces dopamine release by acting on presynaptic receptors.
Our data demonstrate that FGF2 -/- mice have an increased tone and responsiveness of the dopaminergic system and suggest that these animals might represent a model to study disorders that are characterized by an imbalance between glutamatergic and dopaminergic neurotransmission.
碱性成纤维细胞生长因子(FGF2)在大脑皮质发育过程中起关键作用。FGF2基因敲除的小鼠大脑皮质深层内的谷氨酸能神经元数量减少。
我们使用分子和行为分析来研究FGF2基因敲除小鼠皮质纹状体功能的可能改变。
我们发现FGF2缺乏导致纹状体中谷氨酸能纤维完整性的突触前标志物表达降低,即膜兴奋性氨基酸转运体3(EAAT3)和囊泡谷氨酸转运体1(VGLUT1)。FGF2基因敲除小鼠皮质纹状体谷氨酸能功能的降低与在新环境中运动活动增强以及对多巴胺能药物(如可卡因或苯丙胺)的反应性增加有关。通过注射低剂量的多巴胺能激动剂阿扑吗啡(0.1mg/kg)可使FGF2基因敲除小鼠的行为改变恢复正常,阿扑吗啡通过作用于突触前受体来减少多巴胺释放。
我们的数据表明FGF2基因敲除小鼠的多巴胺能系统张力和反应性增加,并表明这些动物可能代表一种研究以谷氨酸能和多巴胺能神经传递失衡为特征的疾病的模型。